Back
American Resources Corp. (Indiana) Vs. Halozyme Therapeutics, Inc. Industry Stock Comparison
Sell
41
AREC
American Resources Corp. (Indiana)
Last Price:
$2.73
Seasonality Move:
201.13%
Buy
62
HALO
Halozyme Therapeutics, Inc.
Last Price:
$70.30
Seasonality Move:
6.84%
Sell
41
American Resources Corp. (Indiana) (AREC)
is a Sell
Is American Resources Corp. (Indiana) a Buy, Sell or Hold?
-
The current American Resources Corp. (Indiana) [AREC] share price is $2.48. The Score for AREC is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
AREC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Halozyme Therapeutics, Inc. [HALO] share price is $67.30. The Score for HALO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AREC Stock Price Chart
What is American Resources Corp. (Indiana)'s stock price today?
-
The American Resources Corp. (Indiana) share price today is $2.48The current trend is relatively stagnant and AREC is experiencing selling pressure, which indicates risk of future bearish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics, Inc.'s stock price today?
-
The Halozyme Therapeutics, Inc. share price today is $67.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight selling pressure.
AREC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 43.76 | Sell |
| Chaikin Money Flow: | -2940190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.39 - 2.89) | Sell |
| Bollinger Bands (100): | (1.95 - 3.83) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 51.52 | Buy |
| Chaikin Money Flow: | -382406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.09 - 69.53) | Buy |
| Bollinger Bands (100): | (65.02 - 73.68) | Sell |
AREC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.52 | Sell |
| 20-day SMA: | 2.62 | Sell |
| 50-day SMA: | 3.13 | Sell |
| 200-day SMA: | 1.88 | Buy |
| 8-day EMA: | 2.56 | Sell |
| 20-day EMA: | 2.64 | Sell |
| 50-day EMA: | 2.86 | Sell |
| 200-day EMA: | 2.2 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.14 | Sell |
| 20-day SMA: | 65.32 | Buy |
| 50-day SMA: | 67.27 | Buy |
| 200-day SMA: | 63.63 | Buy |
| 8-day EMA: | 67.56 | Sell |
| 20-day EMA: | 66.93 | Buy |
| 50-day EMA: | 67.27 | Buy |
| 200-day EMA: | 63.99 | Buy |
American Resources Corp. (Indiana) Earnings Growth & AREC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.47 per share.
Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.88 per share, and an increase next year of $1.43 per share.
American Resources Corp. (Indiana) Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||